A-Z Index
Image Cart
              

 Information For:

Manufacturers

Regulator

Healthcare

Consumers

Members

Revision Bulletin

Midazolam Injection

Posting Date: 30 October 2009; updated 26 February 2010
Official Date: 1 December 2009
Expert Committee: Monograph Development—Pulmonary and Steroids


In accordance with the Rules and Procedures of the 2005-2010 Council of Experts, the Monograph Development-Pulmonary and Steroids Expert Committee has revised the Midazolam Injection monograph based on data provided by an FDA-approved sponsor as follows:

  1. Revised the pH range from "between 2.5 and 3.5" to "between 2.5 and 3.7"
  2. Revised the acceptance criteria for Content of benzyl alcohol from "between 90% and 110% of the labeled amount is found" to "the content of benzyl alcohol meets the requirements for Added Substances under Injections <1>".

This Midazolam Injection Revision Bulletin supersedes the currently official monograph and will be incorporated into First Supplement to the USP 33–NF 28 Reissue.

Should you have any questions, please contact Mary Waddell (301-816-8124 or ).

Download the Midazolam Injection Revision Bulletin  (122KB)